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Summary
The clinical presentations of bacillary dysentery
caused by shigella, and amoebic dysentery caused by
the protozoan parasite 
 
Entamoeba histolytica,
 
 can
be indistinguishable, with both organisms causing
colonic mucosal damage and ulceration. However, the
two organisms are quite distinct, and have very dif-
ferent pathogenic mechanisms. This raises the funda-
mental question of whether the similar clinical
manifestations reﬂect a stereotypic response of the
human gut to mucosal injury, or whether there are
differences at the molecular level in the host response
to individual gut pathogens. To characterize the
human colonic response to each pathogen at the
molecular level, we measured the differential tran-
scription of nearly 40 000 human genes in sections of
human colonic xenografts obtained 4 and 24 h follow-
ing infection with 
 
Shigella ﬂexneri
 
 or 
 
E. histolytica
 
.
Our results indicate that much of the human colonic
response to these two pathogens is stereotypic, with
increased expression of genes activated in cells
undergoing stress and/or hypoxic responses, genes
encoding cytokines, chemokines, and mediators that
are involved in immune and inﬂammatory responses,
and genes encoding proteins involved in responses
to tissue injury and in tissue repair. The responses to
amoeba and 
 
Shigella
 
 were not identical however, and
we found unique elements in each response that may
provide new insights into the distinct pathogenic
mechanisms of 
 
E. histolytica
 
 and 
 
S. ﬂexneri
 
.
Introduction
 
Bacillary dysentery, caused by 
 
Shigella
 
 spp., and amoebic
dysentery, caused by the protozoan parasite 
 
Entamoeba
histolytica
 
, are major threats to public health worldwide.
Both 
 
E. histolytica
 
 and 
 
S. ﬂexneri
 
 speciﬁcally infect human
colon, resulting in colitis, with mucosal ulceration and
inﬂammation. Whereas the clinical manifestations of bacil-
lary dysentery and amoebic dysentery are often indistin-
guishable, the two organisms have very different
pathogenic mechanisms. 
 
Shigella
 
 are primarily intracellu-
lar pathogens that invade into intestinal epithelial cells,
multiply intracellularly, kill the host cell, then spread hori-
zontally into adjacent epithelial cells, or into the lamina
propria. (Tran 
 
et al
 
., 2000). In contrast, 
 
E. histolytica
 
 is an
extracellular pathogen that ingests, but does not reside
within, host cells. Instead, 
 
E. histolytica
 
 trophozoites lyse
human cells by the action of pore-forming molecules, and
digest and invade through the host extracellular matrix by
secreting cysteine proteinases. (Stanley, 2003) Despite
these differences, there are common elements in colitis
caused by 
 
Shigella
 
 and colitis secondary to 
 
E. histolytica
 
infection, as in both infections, the host inﬂammatory
response appears to be a critical component of disease.
Mucosal biopsy samples from individuals with 
 
Shigella
 
show increased levels of proinﬂammatory mediators such
as IL-8, IL-1
 
b
 
, and TNF alpha. (Raqib 
 
et al
 
., 1995) In
studies of 
 
Shigella ﬂexneri
 
 and 
 
E. histolytica
 
 infections in
human colonic xenografts in severe combined immunode-
ﬁcient mice (SCID-HU-INT mice), both 
 
E. histolytica
 
 and
 
Shigella
 
  induced intestinal epithelial cell production of
cytokines and chemokines, including IL-8 and IL-1
 
b
 
(Seydel 
 
et al
 
., 1998; Zhang 
 
et al
 
., 2001). In both infec-
tions, the transcription factor NF-
 
k
 
B may play a key role
in mediating the inﬂammatory response. In the SCID-HU-
INT model of 
 
E. histolytica
 
 infection, NF-
 
k
 
B was required
for activation of cytokine production in intestinal epithelial
cells, the resultant neutrophil inﬂux into the gut mucosa,
and the overall inﬂammatory response that led to tissue
damage. (Seydel 
 
et al
 
., 1998) 
 
Shigella
 
  invasion into
human epithelial cells rapidly activates NF-
 
k
 
B and cytok-
ine production within those cells, through unique LPS-
dependent pathways (Philpott 
 
et al
 
., 2000).
The ﬁnding that two very different pathogens, 
 
E. his-
tolytica
 
 and 
 
S. ﬂexneri
 
, as well as other invasive bacteria,
may induce gut inﬂammation through similar pathways,
raises fundamental questions about the nature of the gut
response to enteric pathogens. Do all pathogens that
damage intestinal epithelial cells induce the same stereo-
typic response within the colon? Or are there pathogen-
speciﬁc responses – pathways for inﬂammation, host
defence, or injury repair that may be induced only by 
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particular types of organisms? To address this question,
we performed a transcriptional analysis, using infection of
SCID-HU-INT mice to compare the human colonic
response to 
 
E. histolytica
 
  and 
 
S.  ﬂexneri
 
  infection. We
measured the differential transcription of nearly 40  000
human genes in sections of human colonic xenografts at
4 and 24 h following infection with 
 
S. ﬂexneri
 
 or 
 
E. histolyt-
ica
 
. Our results indicate that much of the human colonic
response to these two pathogens is similar, and that the
pattern of differentially expressed genes resembles those
seen with inﬂammatory bowel disease, suggesting that
the gut has a limited repertoire of responses to mucosal
injury. The responses to amoeba and 
 
Shigella
 
 were not
identical however, and we ﬁnd unique elements in each
response that may provide new insights into the distinct
pathogenic mechanisms of 
 
E. histolytica
 
 and 
 
S. ﬂexneri
 
.
 
Results
 
Histologic appearance of 
 
E. histolytica
 
 or 
 
S. ﬂexneri
 
 
colonic infection at 4 and 24 h
 
Examples of histologic ﬁndings from human colonic
xenografts with amoebic or shigella infection at 4 and 24 h
are shown in Fig. 1. 
 
Entamoeba histolytica
 
 infection at 4 h
 
Fig. 1.
 
 Photomicrographs of 
 
E. histolytica
 
 or 
 
S. ﬂexneri
 
 infected human colonic xenografts at 4 or 24 h after infection.
A. Section of a human colonic xenograft infected for 4 h with 
 
E. histolytica
 
 trophozoites. Amoebic trophozoites (arrowheads) are seen in the lumen 
with surrounding cellular debris and a minimal inﬂammatory response. Some mucosal damage with denuded portions of villi are seen (large 
arrows). Magniﬁcation 250
 
¥
 
.
B. Section of a human colonic xenograft infected for 24 h with 
 
E. histolytica
 
 trophozoites showing ulceration, marked inﬂammation and tissue 
destruction. There is almost complete loss of normal architecture in the mucosa (M), and masses of 
 
E. histolytica
 
 trophozoites are visible 
(arrowheads) throughout the mucosa and in regions of detached mucosa in the lumen. The submucosa (S) has been inﬁltrated by polymorpho-
nuclear cells. Magniﬁcation 200
 
¥
 
.
C. Section of human colonic xenografts infected for 4 h with 
 
S. ﬂexneri
 
. An ulcer with mucosal disruption and hypercellularity is visible underneath 
the arrow. Mucosal haemorrhage is present, and erythrocytes and neutrophils are present in the lumen. Magniﬁcation 200
 
¥
 
.
D. Section of a human colonic xenograft infected for 24 h with 
 
S. ﬂexneri
 
. Two opposing layers of colonic mucosa are shown, one relatively spared 
(N) and the other markedly involved (I), with loss of normal architecture, ‘ghost’ villi, intense polymorphonuclear cell inﬁltration extending into the 
lumen, and mucosal haemorrhage. Arrows indicate villous and crypt remnants. The submucosal region is relatively spared. Magniﬁcation 200
 
¥
 
. 
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is associated with some mucosal damage, the presence
of a few inﬂammatory cells in the colonic lumen, and
minimal to no invasion into submucosal tissues (Fig. 1A).
At 24 h of infection, 
 
E. histolytica
 
 has caused signiﬁcant
mucosal damage, with amoebic trophozoites invading into
submucosal tissues, some mucosal hemorrhage, and a
marked inﬂammatory inﬁltrate, primarily neutrophils, in the
submucosal region (Fig. 1B). 
 
Shigella ﬂexneri
 
 infection at
4  h causes some mucosal damage associated with
mucosal inﬂammation and some mucosal haemorrhage,
but submucosal tissues appear uninvolved (Fig. 1C). At
24 h of infection, 
 
S. ﬂexneri
 
 infection has caused diffuse
mucosal damage, with only a few remnants of normal
mucosa remaining in involved areas, marked hemorrhage,
but relatively little evidence for submucosal invasion
(Fig.  1D). These data indicate that the inﬂammatory
response and the levels of mucosal damage should be
most marked in 
 
E. histolytica
 
  infection at 24  h and 
 
S.
ﬂexneri
 
 infection at 4 and 24 h.
 
Comparative transcriptional analysis of 
 
E. histolytica
 
 and 
 
S. ﬂexneri
 
 colonic infection at 4 and 24 h: genes showing 
increased expression in both 
 
E. histolytica
 
 and 
 
S. ﬂexneri
 
 
infection
 
The  complete  data  for  all  genes  in  all  the  experi-
ments performed using the Stanford arrays and the
conﬁrmatory Incyte experiments are available at http://
stanleylab.wustl.edu/ehmd. We found 148 genes that
showed increased expression in both 
 
E. histolytica
 
 and 
 
S.
ﬂexneri
 
 infection compared to uninfected human colonic
xenografts at one or both of the two time-points (data for
each of the experiments is shown in Fig. 2, whereas mean
values and gene groupings are shown in Table  1). Of
these 148 genes, 81 were represented on the Incyte Uni-
gene-based array, and 61/81 (75%) showed the same
expression pattern in the conﬁrmatory experiment
(marked ‘C’ for conﬁrmed next to the gene name) (Fig. 2).
The 148 genes expressed at higher levels in both 
 
S.
ﬂexneri
 
 and 
 
E. histolytica
 
 infection fell into several catego-
ries (Table 1). Many were genes known to be activated in
cells undergoing stress and/or hypoxic responses [e.g.
nine members of the metallothionein family (Davis and
Cousins, 2000), c-Jun and c-Fos family members (Weston
and Davis, 2002), hypoxia-inducible factor-1 (HIF-1)
(Huang and Bunn, 2003), immediate early response 3,
serum amyloid proteins (He and Sang, 2003), DAF
(Andoh 
 
et al
 
., 2001), heat-shock proteins, growth-arrest
and DNA-damage-inducible 3 (Bosio 
 
et al
 
., 2002), alpha
crystallin (Narberhaus, 2002), vacuole-membrane protein
(Dusetti 
 
et al
 
., 2002)]. Previous studies in the SCID-HU-
INT model had revealed signiﬁcant increases in the
expression of genes encoding IL-1
 
b
 
, IL-8, and COX-2 with
 
E. histolytica
 
 infection, and increases in IL-1
 
b
 
 and IL-8 in
 
S.  ﬂexneri
 
 infection (Seydel 
 
et al
 
., 1997; Stenson 
 
et al
 
.,
2001; Zhang 
 
et al
 
., 2001). These ﬁndings were conﬁrmed
in the microarray analysis, and the expression of genes
encoding a number of other cytokines, chemokines and
mediators that are involved in immune and inﬂammatory
responses was also found to be increased in both
 
E. histolytica
 
  and 
 
S.  ﬂexneri
 
  infection (Table  1). This
included the interleukin-1 receptor, interleukin-6, multiple
TNF-
 
a
 
-induced proteins, several interferon 
 
g
 
-induced pro-
teins, all 3 GRO-family members, superoxide dismutase
2, monocyte chemotactic protein (MCP)-1, MCP-2, MCP-
3, ENA-78, MIP-3
 
a
 
, leukaemia-inhibitory-factor, lipocalin
2 (Devireddy 
 
et al
 
., 2001), and leukotriene C4 synthase.
Many of the genes expressed at higher levels in 
 
E. his-
tolytica
 
 and 
 
S. ﬂexneri
 
 infection encode proteins involved
in responses to tissue injury and in tissue repair and
remodelling (e.g. matrix metalloproteinase (MMP) 1,
MMP12, MMP17 (Vincenti and Brinckerhoff, 2001), tissue
inhibitor of metalloproteinase 1 (TIMP1), tissue factor
pathway inhibitor 2, cryptic protein, connective tissue
growth factor, cysteine-rich angiogenic inducer, angiopoe-
itin-like 4, stanniocalcin 1, thrombospondin 1, ICAM-1,
tenascin, TGF-
 
b
 
 induced protein 68 (kDa). The increased
expression of several genes encoding metabolic enzymes
known to be expressed in response to hypoxia (e.g.
lactate dehydrogenase A, enolase 1 and 2, fructose
bisphosphate aldolase, glyceraldehyde-3-phosphate
dehydrogenase) (Semenza 
 
et al
 
., 1996; Lu 
 
et al
 
., 2002)
or glucocorticoids (6-phosphofructo-2-kinase/fructose-
2,6-bisphosphatase 3) (Lange 
 
et al
 
., 1992) was also
found.
As shown in Fig. 2, most of the 148 genes expressed
at higher levels in human colonic xenografts infected with
amoeba or shigella showed increased expression at all
four time-points, or at the three time-points where colonic
inﬂammation and tissue destruction was most prominent
– amoebic infection at 24 h and shigella infection at both
4 and 24 h. There were a few genes that appeared to be
speciﬁcally expressed late in 
 
E. histolytica
 
 and 
 
S. ﬂexneri
 
infection (e.g. interleukin-11, serine/cysteine proteinase
inhibitor clade E, COX-2), and a few genes that were
expressed only early in both 
 
E. histolytica
 
 and 
 
S. ﬂexneri
 
infection (e.g. junD, protein phosphatase 2 catalytic sub-
unit, protein tyrosine phosphatase type IVA member 1,
interferon-stimulated protein 15 kDa). In general, among
individual genes showing increased expression in both
 
E. histolytica
 
 and 
 
S. ﬂexneri
 
 infection, differential expres-
sion ratios were higher in the S. ﬂexneri-infected human
colonic xenografts (Fig. 2).
Genes showing increased expression in S. ﬂexneri 
infection but not E. histolytica infection
We  found 81 genes that met criteria for increased538 Z. Zhang and S. L. Stanley, Jr
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Fig. 2. Genes differentially expressed in both 
E. histolytica and S. ﬂexneri infected human 
colonic xenografts at 4 and/or 24 h of infection. 
Gene expression proﬁles from three experi-
ments looking at E. histolytica infection at 4 h 
(A4), three experiments looking at E. histolytica 
infection at 24 h (A24) and three experiments 
looking at S. ﬂexneri infection at 4 h (S4) or 24 h 
(S24) are shown. Genes are listed by gene 
name, and those genes showing a similar 
expression pattern in the conﬁrmatory experi-
ments using the Unigene array are marked by 
a (C). Those genes that were represented on 
the Unigene array but did not exhibit the same 
expression pattern are marked as (NC). The 
data are expressed as the log2 of the expres-
sion ratio, and the key for intensity of expression 
is:   Grey bars signify 
missing values secondary to failure of a given 
gene spot to meet minimal intensity require-
ments for that experiment.Human colonic transcriptional response to dysentery 539
© 2004 Blackwell Publishing Ltd, Cellular Microbiology, 6, 535–554
Table 1. Genes showing increased expression in both E. histolytica and S. ﬂexneri infection at one or both time-points.
Gene name Accession A4 A24 S4 S24
Stress response
apolipoprotein E T70891 1.8 ± 0.19 1.71 ± 0.29 2.88 ± 0.32 2.09 ± 0.12
cold shock domain protein A AA455300 0.99 ± 0.21 2.27 ± 0.21 3.97 ± 2.19 5.53 ± 1.35
crystallin, alpha B AA504891 2.32 ± 0.16 2.45 ± 0.01 4.43 ± 0.87 9.54 ± 3.71
DNA2 DNA replication helicase 2-like (yeast) AI248069 3.24 ± 0.6 2.27 ± 0.44 9.84 ± 4.83 7.47 ± 2.24
EST, Moderately similar to Cd-7 metallothionein-2 [H.sapiens] R16539 7.99 ± 2.25 3.08 ± 0.46 5.31 ± 2.34 7.65 ± 1.56
growth arrest and DNA-damage-inducible, beta AA504354 6.83 ± 2.14 2.36 ± 0.37 3.64 ± 0.61 8.46 ± 4.44
H.sapiens mRNA for metallothionein isoform 1R AI289110 7.34 ± 1.3 3.44 ± 0.52 19.61 ± 1.14 18.65 ± 3.55
haptoglobin
heat shock 70 kDa protein 1-like
AI985788
H17513
2.26 ± 0.45
1.42 ± 0.24
18.8 ± 12.4
1.74 ± 0.14
3.01 ± 1.03
1.3 ± 0.59
26.12 ± 19.01
21.22 ± 11.18
HIF-1 responsive RTP801 AA447746 5.09 ± 1.48 3.82 ± 0.91 3.43 ± 1.48 10.04 ± 4.12
Homo sapiens clone MT1Y metallothionein 1Y mRNA,
complete cds
R06601 12.77 ± 3.4 4.28 ± 1.5 18.12 ± 8.91 22.4 ± 3.66
hypoxia-inducible factor 1, alpha subunit W47003 3.43 ± 0.44 1.73 ± 0.28 3.24 ± 0.61 7.26 ± 1.84
immediate early response 3 AA457705 2.48 ± 0.75 7.63 ± 3.57 5.66 ± 2.98 28.17 ± 16.81
likely orthologue of rat vacuole membrane protein 1 AA159669 3.24 ± 1.22 1.52 ± 0.3 1.69 ± 0.22 3.82 ± 0.35
metallothionein 1F N55459 8.28 ± 2.97 3.9 ± 1.16 25.82 ± 3.24 39.83 ± 19.47
metallothionein 1G H53339 7.33 ± 1.59 2.65 ± 0.24 49.67 ± 25.82 13.87 ± 6.69
metallothionein 1H H77597 7.47 ± 3.19 11.5 ± 2.59 34.59 ± 17.84 11.75 ± 0.43
metallothionein 1 l N80129 8.92 ± 0.95 5.04 ± 1.17 25.7 ± 11.24 17.54 ± 5.05
metallothionein 2 A AA156031 10.76 ± 1.57 4.32 ± 0.56 40.38 ± 2.66 42.36 ± 0.75
metallothionein 3 [growth inhibitory factor (neurotrophic)] AI362950 6.38 ± 2.46 6.08 ± 0.96 13.99 ± 4.6 15.66 ± 2.56
serum amyloid A1 H25546 2.83 ± 0.72 8.36 ± 2.97 10.78 ± 5.23 47.18 ± 4.49
serum amyloid A2 AI659145 17.13 ± 11.43 28.99 ± 9.18 6.02 ± 3.08 41.05 ± 8.25
serum amyloid A4, constitutive AI344545 5.64 ± 0.12 21.67 ± 6.73  –  ± – 30.37  ± 22.25
uncoupling protein 2 (mitochondrial, proton carrier) H61242 4.52 ± 1.2 1.45 ± 0.21 6.06 ± 1.51 9.28 ± 5.05
Immune response/Inﬂammatory mediators/Cytokines/Chemokines
ENA-78 AA878880 5.23 ± 1.41 3.97 ± 0.72 2.13 ± 0.47 7.42 ± 2.9
decay accelerating factor for complement (CD55) R09561 4.15 ± 0.60 3.22 ± 0.44 2.48 ± 0.27 2.01 ± 1.04
GRO1 oncogene (melanoma growth stimulating activity, alpha) W42723 8.63 ± 2.41 12.65 ± 3.98 9.57 ± 2.41 38.17 ± 2.71
GRO2 oncogene R47771 7.32 ± 3.16 3.88 ± 0.81 4.92 ± 2.29 23.22 ± 10.03
GRO3 oncogene AA935273 6.4 ± 2.84 6.02 ± 1.63 7.69 ± 3.58 25.18 ± 6.74
homologous to PBEF AA281932 5.82 ± 0.45 3.82 ± 0.66 8.86 ± 2.68 15.73 ± 2.2
hypothetical SBBI03 protein (homology with TRAF-2) AI299601 7.81 ± 4.81 4.09 ± 0.77 21.71 ± 6.57 14.4 ± 0.78
interferon induced transmembrane protein 3 (1–8 U) AA464416 1.57 ± 0.22 2.22 ± 0.16 2.95 ± 0.67 4.16 ± 0.69
interferon regulatory factor 7 AA477347 2.89 ± 0.03 1.73 ± 0.27 6.25 ± 0.6 6.56 ± 2.7
interferon stimulated gene (20 kDa) AA150500 4.63 ± 0.39 2.62 ± 0.16 1.43 ± 0.66 3.92 ± 0.61
interferon-stimulated protein, 15 kDa AA120862 4.32 ± 2.33 0.68 ± 0.1 4.24 ± 1.63 0.6 ± 0.26
interleukin 1 receptor type 1 R56687 2.03 ± 0.78 1.80 ± 0.24 3.97 ± 0.85 8.17 ± 4.45
interleukin 1, beta W47101 1.35 ± 0.54 12.43 ± 1.97 4.14 ± 0.58 13.07 ± 8.29
interleukin 11 AI148233 0.94 ± 0.41 19.84 ± 4.02 0.52 ± 0.1 15.22 ± 4.07
interleukin 4 receptor AA292025 2.91 ± 1.07 1.01 ± 0.34 1.27 ± 0.42 2.41 ± 0.87
interleukin 6 (interferon, beta 2) N98591 1.51 ± 0.59 8.92 ± 6.28 2.97 ± 0.32 17.79 ± 2.38
interleukin 8 AA082747 1.66 ± 0.44 1.64 ± 0.31 11.34 ± 10.66 5.83 ± 0.56
leukaemia inhibitory factor (cholinergic differentiation factor) R50018 1.26 ± 0.66 4.08 ± 1.29 4.63 ± 3.17 7.55 ± 1.36
leukotriene C4 synthase AI299075 3.62 ± 0.89 3.43 ± 0.98 4.9 ± 2.51 5.07 ± 0.7
lipocalin 2 (oncogene 24p3) AA400973 2.43 ± 0.54 7.61 ± 2.36 2.95 ± 0.85 6.9 ± 2.89
MIP-3a (small inducible cytokine subfamily A (Cys-Cys),
member (20)
AI285199 18.78 ± 1.88 5.32 ± 2.2 3.67 ± 0.48 5.85 ± 3.36
monocyte chemotactic protein 1 AA425102 3.96 ± 0.49 2.5 ± 0.29 25.56 ± 7.19 40.98 ± 20.33
monocyte chemotactic protein 2 AI268937 1.44 ± 0.73  2 ± 0.66 12.15 ± 4.36 10.6 ± 2.58
monocyte chemotactic protein 3 AA040170 2.53 ± 0.19 2.05 ± 0.81 5.17 ± 2.48 3.66 ± 1.5
pre-B-cell colony-enhancing factor AI335002 2.72 ± 0.17 1.38 ± 0.45 5.26 ± 0.45 6.28 ± 0.42
COX-2 R80217 0.88 ± 0.43 8.47 ± 1.72 5.19 ± 2.56 9.81 ± 0.49
prostate differentiation factor (MIC-1) AA450062 5.35 ± 1.82 3.1 ± 0.96 2.25 ± 0.53 10.3 ± 2.42
S100 calcium binding protein A9 (calgranulin B) AA864554 0.7 ± 0.12 2.32 ± 0.31 0.9 ± 0.39 9.7 ± 3.87
superoxide dismutase 2, mitochondrial W78148 5.15 ± 0.82 3.53 ± 0.48 7.06 ± 1.92 13.43 ± 2.63
tumor necrosis factor, alpha-induced protein 3 AA433807 7.84 ± 1.53 3.59 ± 0.1 14.64 ± 7.16 18.83 ± 10.44
type I transmembrane protein Fn14 (TWEAK receptor) AI221536 7.31 ± 3.44 3.7 ± 0.21 4.42 ± 1.52 3.88 ± 0.7
vasoactive intestinal peptide AI217172 0.6 ± 0.1 2.4 ± 0.35 5.63 ± 4.17 8.55 ± 2.14
Growth factors/Tissue Remodeling/Cell Cycle Regulators/Apoptosis-related/Oncogenes
adipose differentiation-related protein AA142916 2.9 ± 0.73 1.61 ± 0.26  3 ± 0.51 8.16 ± 1.18
angiopoietin-like 4 T53705 2.37 ± 0.12 12.09 ± 4.61 1.13 ± 0.66 6.94 ± 1.63
baculoviral IAP repeat-containing 5 (survivin) AA460685 5.42 ± 2.01 3.06 ± 0.43 18.26 ± 4 15.39 ± 5.57
BCL2-associated athanogene 3 AI371684 3.33 ± 1.14 1.52 ± 0.42 6.74 ± 0.91 4.9 ± 2.53
colony stimulating factor 1 receptor R92609 2.71 ± 0.84 1.03 ± 0.26 3.87 ± 1.13 4.08 ± 1.06
connective tissue growth factor AA598794 5.88 ± 0.09 3.06 ± 0.18 15.26 ± 9.25 7.3 ± 2.49
cryptic gene AA878309 5.34 ± 1.03 2.86 ± 0.33 5.16 ± 0.2 11.96 ± 3.21
cyclin-dependent kinase 5 AA401479 2.13 ± 0.77 3.01 ± 0.69 11.06 ± 0.55 5.24 ± 1.28540 Z. Zhang and S. L. Stanley, Jr
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cysteine knot superfamily 1, BMP antagonist 1 W47324 1.36 ± 0.42 2.2 ± 0.17 7.12 ± 2.17 8.99 ± 2.15
cysteine-rich, angiogenic inducer, 61 AI014487 5.7 ± 0.88 2.53 ± 0.2 7.55 ± 1.09 14.32 ± 6.17
endothelin receptor type A AA450009 2.82 ± 1.71 3.15 ± 0.66 17.85 ± 10.98 11.95 ± 6.19
follistatin AI214697 3.03 ± 2.16 5.34 ± 2.07 6.02 ± 4.83 48.46 ± 16.23
GTP binding protein overexpressed in skeletal muscle AA418077 0.74 ± 0.03 4.92 ± 1.22 13.69 ± 11.06 77.57 ± 33.61
H3 histone, family 3B (H3.3B) AA608514 2.94 ± 0.41 1.17 ± 0.03  3 ± 0.25 3.71 ± 0.58
hexabrachion (tenascin C, cytotactin) AW075585 1.38 ± 0.62 3.11 ± 0.61 6.7 ± 3.44 9.63 ± 4.8
keratin 17 AA159201 1.02 ± 0.04 3.69 ± 1.11 7.55 ± 4.64 1.88 ± 0.33
keratin 19 AA464250 1.19 ± 0.26 3.67 ± 0.48 2.34 ± 0.28 4.53 ± 1.72
laminin, alpha 4 R43734 3.23 ± 0.19 0.88 ± 0.18 2.18 ± 0.12 3.94 ± 0.05
matrix metalloproteinase 1 (interstitial collagenase)
matrix metalloproteinase 12 (macrophage elastase)
matrix metalloproteinase 17 (membrane-inserted)
AA143201
R92994
R17506
 3 ± 1.55
3.31 ± 1.13
2.04 ± 0.58
7.35 ± 2.2
4.66 ± 1.5
3.85 ± 1.02
1.48 ± 0.53
3.58 ± 0.69
5.1 ± 2.9
2.57 ± 0.31
5.31 ± 1.71
5.37 ± 2.53
milk fat globule-EGF factor 8 protein AA054753 4.05 ± 0.41 0.69 ± 0.07 2.74 ± 1.35 1.97 ± 0.36
proline rich 2 AA669637 4.09 ± 1.25 1.08 ± 0.29  – ± – 3.65  ± 1.61
proteoglycan 1, secretory granule AA278759 2.78 ± 0.31 3.75 ± 0.32 4.31 ± 0.95 11.02 ± 1.13
putative lymphocyte G0/G1 switch gene AA931758 1.51 ± 0.32 5.86 ± 0.68 4.16 ± 1.47 19.65 ± 4.78
ret proto-oncogene H24956 4.65 ± 1.63 2.08 ± 0.11 5.51 ± 3.09 3.32 ±1.68
Similar to serine (or cysteine) proteinase inhibitor, clade E
member 2,
stanniocalcin 1
N57754
AA126561
1.01 ± 0.16
2.43 ± 1.57
4.2 ± 0.39
6.07 ± 1.35
0.81 ± 0.07
 – ± – 
9.26 ± 1.92
28.57 ± 11.95
tetraspan 1 AI674349 2.09 ± 0.92 3.12 ± 0.34 1.63 ± 1.09 1.15 ± 0.07
thrombospondin 1 AA007557 1.87 ± 0.33 4.29 ± 1.38 4.48 ± 0.48 9.22 ± 0.43
thyroid hormone receptor (v-erb-a) oncogene homologue,
avian)
R60006 3.68 ± 1.04 1.49 ± 0.19 4.91 ± 1.12 3.33 ± 1.3
tissue factor pathway inhibitor 2 AA293402 3.45 ± 1.66 4.15 ± 0.47 3.88 ± 3.48 17.03 ± 8.93
tissue inhibitor of metalloproteinase 1 AA284534 0.98 ± 0.08 4.1 ± 0.66 7.86 ± 0.59 45.95 ± 14.06
transforming growth factor, beta-induced, 68 kDa AA633901 1.54 ± 0.48 2.85 ± 0.41 1.06 ± 0.46 6.32 ± 1.31
Signalling molecules/Transcription factors
jun B proto-oncogene AA454711 5.67 ± 0.71 2.42 ± 0.27 9.84 ± 1.82 6.63 ± 1.94
jun D proto-oncogene AA418670 2.51 ± 0.36 0.71 ± 0.08 2.67 ± 0.94 0.99 ± 0.36
mitogen activated protein kinase kinase 3 AA829383 3.62 ± 1.78 1.3 ± 0.37 1.98 ± 0.41 5.02 ± 1.91
nuclear factor of kappa light polypeptide gene enhancer in
B-cells inhibitor, alpha
W55872 5.28 ± 0.27 1.21 ± 0.27 5.73 ± 2.29 4.57 ± 0.47
pellino homologue 1 (Drosophila) H72755 5.13 ± 3.17 0.88 ± 0.09 0.45 ± 0.04 2.15 ± 0.09
protein phosphatase 2 (formerly 2 A), catalytic subunit, beta
isoform
AA490473 1.71 ± 0.31 0.84 ± 0.15 2.84 ± 1.14 1.09 ± 0.53
protein tyrosine phosphatase type IVA, member 1 AA482193 2.12 ± 0.89 1.25 ± 0.14 2.51 ± 0.37 1.3 ± 0.28
retinoic acid induced 3 AA172400 4.71 ± 0.44 2.68 ± 0.12 3.79 ± 0.55 1.93 ± 1.11
sequestosome 1 AW074995 3.52 ± 0.95 1.06 ± 0.22 3.55 ± 1.36 3.8 ± 1.13
STAT induced STAT inhibitor 3 AI922872 11.5 ± 2.49 6.02 ± 1.94 2.92 ± 0.44 7.38 ± 2.59
transcription elongation factor B (SIII), polypeptide 3 (110 kDa,
elongin A)
AA128607 5.52 ± 1.45 4.48 ± 0.83 17.5 ± 7.19 3.48 ± 1.47
translation factor sui1 homologue AA488391 2.15 ± 0.15 1.57 ± 0.24 3.14 ± 0.9 2.53 ± 0.43
v-fos FBJ murine osteosarcoma viral oncogene homologue R12840 9.58 ± 1.31 3.95 ± 1.04 7.6 ± 3.85 5.07 ± 0.91
v-jun sarcoma virus 17 oncogene homologue (avian) AA293362 2.72 ± 0.44 0.87 ± 0.23 5.22 ± 1.26 2.5 ± 0.06
v-myc myelocytomatosis viral oncogene homologue (avian) W87741 3.76 ± 0.78 2.69 ± 0.87 5.14 ± 0.26 4.11 ± 1.52
zinc ﬁnger protein 36, C3H type, homologue (mouse) R38383 4.34 ± 1.26 1.61 ± 0.32 5.11 ± 0.97 3.02 ± 0.35
Metabolic enzymes
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 N64010 12.14 ± 1.79 3.77 ± 0.75 8.98 ± 7.53 5.73 ± 1.94
alanine-glyoxylate aminotransferase N57872 10.18 ± 1.1 3.59 ± 0.22 29.84 ± 11.45 16.33 ± 2.42
enolase 1 (alpha) AI001174 0.97 ± 0.11 2.43 ± 0.36 1.56 ± 0.38 2.61 ± 0.56
enolase 2 (gamma, neuronal) AI969131 1.9 ± 0.11 5.01 ± 2.04 1.28 ± 0.36 8.35 ± 3.92
EST, Highly similar to I39435 fructose-bisphosphate aldolase
[H.sapiens]
AA977896 3.17 ± 0.06 2.58 ± 0.55 6.26 ± 1.65 22.61 ± 15.18
glyceraldehyde-3-phosphate dehydrogenase AA197335 0.84 ± 0.21  3 ± 0.31 3.55 ± 3.01 2.37 ± 1.11
lactate dehydrogenase A AA489611 1.48 ± 0.07 2.03 ± 0.19 1.88 ± 0.38 2.77 ± 0.93
ornithine decarboxylase 1 AA460115 2.54 ± 0.41 1.86 ± 0.61 1.61 ± 0.56 2.29 ± 0.11
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyl-
transferase 6
AI300634 9.72 ± 5.25 5.01 ± 1.82 14.98 ± 3.81 25.53 ± 8.79
Clotting/haemorrhage
haemoglobin, alpha 2 AA027832 0.86 ± 0.11 5.14 ± 2.01 26.86 ± 22.75 15.63 ± 5.69
haemoglobin, beta AI927438 0.94 ± 0.14 4.45 ± 0.85 4.89 ± 1.45 3.69 ± 0.79
haemoglobin, gamma A H94956 1.1 ± 0.64 4.3 ± 1.66 1.75 ± 0.45 0.86 ± 0.04
haemoglobin, gamma G N68719 1.31 ± 0.04 4.31 ± 0.61 4.45 ± 1.24 5.43 ± 0.39
plasminogen activator, tissue AA447797 2.56 ± 0.91 3.02 ± 0.37 6.51 ± 2.9 3.04 ± 1.03
plasminogen activator, urokinase AA284668 3.87 ± 1.46 3.07 ± 0.06 9.55 ± 2.31 25.36 ± 21.25
Gene name Accession A4 A24 S4 S24
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expression in shigella-infected human colonic xenografts,
but did not meet the criteria for increased expression in
amoeba-infected xenografts (Table 2, Fig. 3). Fifty-four of
these genes were also represented on the Incyte array,
and 44/54 (81%) were conﬁrmed as showing a similar
expression pattern to that detected in the Stanford arrays.
Many of the genes in this group were expressed at high
levels in S. ﬂexneri infection at 4 h, but not at the other
time-points (Fig. 3). The largest grouping among shigella-
speciﬁc genes was those genes encoding proteins that
are involved in cytoskeletal rearrangements or cell motility
(Table 2). The genes encoding the intermediate ﬁlament
proteins, vimentin and desmin, the microtubule-related
protein dynein, the actin-interacting proteins caldesmon,
smoothelin, transgelin (TAGLN), gelsolin, moesin, ponsin,
myosin, tropomyosin, as well as several isoforms of actin
itself, all showed higher expression in human colonic
xenografts infected with S. ﬂexneri. The increased expres-
sion of genes encoding a group of proteins that may
regulate cytokine signalling (elongin C, SWIP-1, and the
WD-repeat protein) (Kamura et al., 1998) was also
detected in S. ﬂexneri-infected human colonic xenografts.
Several genes encoding proteins linked to the regulation
of cellular proliferation or apoptosis were identiﬁed as
shigella-speciﬁc, including galectin 1, programmed cell-
death 5, BTG family member 2, thymosin b-10, and
ubiquinone. Three members of the large RGS family (reg-
ulators of G-protein-signalling) were also speciﬁcally
increased in S. ﬂexneri infection. Two chemokines, eotaxin
and tyrosyl-t-RNA synthetase, were up-regulated in
S. ﬂexneri infection, but not in E. histolytica-infected colon
(Table 2).
Genes showing increased expression in E. histolytica 
infection, but not S. ﬂexneri infection
Only 39 genes that met criteria for increased expression
in E. histolytica-infected human colonic xenografts but not
in  S.  ﬂexneri-infected xenografts were found (Table  3,
Fig.  4). Twenty-seven of these genes were also
Motility and adherence
carcinoembryonic antigen-related cell adhesion molecule 5 AA055605 1.29 ± 0.51 2.91 ± 0.01 0.97 ± 0.39 4.29 ± 2.2
coronin, actin binding protein, 1 A AA047477 0.78 ± 0.03 2.82 ± 0.45 1.71 ± 0.36 3.69 ± 0.54
ﬁlamin (human actin binding protein C) T64982 2.46 ± 0.96 2.21 ± 0.12 2.96 ± 1.79 5.9 ± 4.5
homologous to supervillin T57810 4.59 ± 1.18 3.24 ± 0.69 9.35 ± 2.65 8.94 ± 1.6
intercellular adhesion molecule 1 (CD54), human rhinovirus
receptor
N68859  4 ± 1.05 3.12 ± 0.35 13.83 ± 5.21 10.29 ± 3.38
plectin 1, intermediate ﬁlament binding protein, 500 kDa AA448400 2.23 ± 0.41 1.07 ± 0.2 2.96 ± 0.78 1.48 ± 0.92
Transporters
solute carrier family 15 (H
+/peptide transporter), member 2 AA425352 4.23 ± 1.68 2.93 ± 0.18 23.9 ± 13.56 6.15 ± 0.61
solute carrier family 2 (facilitated glucose transporter),
member 1
R11688 6.43 ± 1.99 7.31 ± 1.26 5.17 ± 3.17 24.33 ± 16.79
solute carrier family 16 (monocaborxylic acid transporters),
member 3
AA129777 3.89 ± 0.79 3.05 ± 0.49 2.88 ± 0.63 7.70 ± 1.24
Unknown
AA121141 AA121141 1.44 ± 0.22 2.55 ± 0.33 2.28 ± 0.35 7.05 ± 2.24
AA128925 AA128925 3.9 ± 0.68 2.25 ± 0.26 6.05 ± 0.94 3.22 ± 0.93
chromosome 8 open reading frame 4 H16793 3.04 ± 0.57 4.43 ± 0.67 4.01 ± 0.73 9.95 ± 4.62
erythrocyte membrane protein band 7.2 (stomatin) R62817 1.59 ± 0.42 2.52 ± 0.52 0.7 ± 0.27 7.34 ± 4.5
ESTs, Weakly similar to T28770 hypothetical protein W03D2.1 AI003775 3.91 ± 1 2.68 ± 0.53 11.1 ± 3.94 17.7 ± 5.48
H73321 H73321 4.08 ± 2.02 2.59 ± 0.28 10.86 ± 3 23.17 ± 10.11
Homo sapiens mRNA; cDNA DKFZp564C2063 AA135912 4.3 ± 1.04 0.93 ± 0.24 6.07 ± 2.78 4.98 ± 1.71
Homo sapiens, clone MGC:12617 IMAGE:2964706, mRNA,
complete cds
H71824 8.46 ± 3.71 10.44 ± 7.01 5.94 ± 1.25 7.99 ± 1.42
homologous to yeast nitrogen permease (candidate tumor
suppressor)
AI222722 2.56 ± 0.82 2.14 ± 0.66 7.36 ± 0.92 4.71 ± 0.09
Human mRNA for ZFM1 protein alternatively spliced product AI356319 1.38 ± 0.52 5.42 ± 2.97 6.77 ± 2.91 2.85 ± 0.46
hypothetical protein FLJ23138 H26181 3.3 ± 1.15 2.31 ± 0.01 4.56 ± 0.16 3.09 ± 0.12
nuclear receptor subfamily 4, group A, member 1 N94487 3.01 ± 0.52 1.64 ± 0.14 10.73 ± 5.33 16.14 ± 10.58
Similar to RNA helicase-related protein, clone MGC:9246
IMAGE:3892441
AA872383 7.48 ± 2.35 2.83 ± 0.1 9.62 ± 0.63 9.38 ± 1.35
SUID310180 3.65 ± 1.56 4.1 ± 1.97 5.97 ± 0.54 8.96 ± 1.98
SUID310693 1.55 ± 0.5 2.6 ± 0.39 1.76 ± 0.03 15.89 ± 10.35
SUID310866 2.67 ± 0.35 3.57 ± 1.33 7.04 ± 4.03 4.02 ± 0.9
The gene name, accession number, and mean fold increase (over the values from uninfected human colonic xenografts) from the replicates ± the
standard error of the mean are shown for each gene in E. histolytica infection at 4 h (A4), 24 h (A24), and S. ﬂexneri infection at 4 h (S4) and
24 h (S24). When intensity values did not meet criteria to allow a mean to be obtained for a given gene at a given time-point, - ± - is shown.
Genes were placed within categories based on known functions or the functions of homologues.
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Table 2. Genes showing increased expression in S. ﬂexneri infection but not E. histolytica infection at one or both time-points.
Gene name Accession A4 A24 S4 S24
Stress response
amyloid beta (A4) precursor protein (protease nexin-II,
Alzheimer disease)
AA128501 0.75 ± 0.09 1.56 ± 0.34 1.64 ± 0.36 3.89 ± 1.45
heat shock 90 kDa protein 1, beta AW075411 1.16 ± 0.23 1.35 ± 0.13 1.57 ± 0.49 2.64 ± 0.8
Similar to heat shock protein, 30 kDa, clone MGC:17057
IMAGE:4345594
AA064917 1.11 ± 0.2 1.05 ± 0.16 2.03 ± 0.83 3.76 ± 0.94
NADH dehydrogenase (ubiquinone) AA214053 0.77 ± 0.23 0.78 ± 0.04 2.28 ± 0.27 1.62 ± 0.57
Immune response/Inﬂammatory mediators/Cytokines/Chemokines
complement component 1, s subcomponent T62048 1.27 ± 0.19 1.11 ± 0.3 2.42 ± 0.31 3.04 ± 1.04
interferon induced transmembrane protein 1 (9–27) AA058323 1.04 ± 0.41 1.21 ± 0.26 6.27 ± 2.8 3.6 ± 1.41
interferon induced transmembrane protein 2 (1–8D) AA985421 1.17 ± 0.12 1.13 ± 0.21 3.58 ± 0.64 3.93 ± 1.35
small inducible cytokine subfamily A (Cys-Cys), member 11
(eotaxin)
SOCS box-containing WD protein SWiP-1
tyrosyl-tRNA synthetase
W69211
R27345
AA486761
0.72 ± 0.2
0.95 ± 0.27
1.26 ± 0.24
1.09 ± 0.23
1.23 ± 0.12
0.71 ± 0.14
57.71 ± 50.53
2.08 ± 0.67
2.32 ± 0.36
2.63 ± 1.12
2.01 ± 0.06
2.98 ± 1.04
WD-repeat protein AI935306 0.96 ± 0.3 0.38 ± 0.09 5.63 ± 0.34 1.28 ± 0.4
Growth Factors/Tissue Remodelling/Cell Cycle Regulators/Apoptosis-related
annexin A1 H63077 1.11 ± 0.22  1 ± 0.05 3.18 ± 0.98 2.89 ± 0.1
ATP-binding cassette, subfamily C (CFTR/MRP), member 1
BTG family, member 2
AA424804
H69582
1.72 ± 0.35
1.84 ± 0.63
1.55 ± 0.18
1.36 ± 0.34
3.91 ± 1.48
4.44 ± 2.9
3.98 ± 1.56
17.85 ± 15.56
cargo sorting protein – mannose 6 phosphate receptor
binding protein
CD53 antigen
AA416787
H70124
1.87 ± 0.49
2.16 ± 0.33
1.15 ± 0.23
1.72 ± 0.43
4.79 ± 1.82
11.88 ± 3.48
1.4 ± 0.59
15.62 ± 9.52
collagen, type I, alpha 1 R48843 0.68 ± 0.18 0.41 ± 0.11 2.34 ± 0.43 0.45 ± 0.13
collagen, type I, alpha 2 AA490172 0.91 ± 0.22 0.38 ± 0.02 2.06 ± 0.31 0.38 ± 0.15
collagen, type IV, alpha 1 R78225 0.49 ± 0.12 0.97 ± 0.19 4.6 ± 1.12 5.64 ± 0.89
collagen, type IV, alpha 2 AA430540 1.11 ± 0.43 1.5 ± 0.36 1.85 ± 0.48 2.68 ± 0.68
collagen, type V, alpha 2 AA461456 2.46 ± 0.76 0.54 ± 0.04 3.92 ± 1.74 1.26 ± 0.73
collagen, type VI, alpha 3 R62603 0.87 ± 0.05 0.78 ± 0.09 3.01 ± 0.48 1.78 ± 0.19
C-type lectin, superfamily member 2 (activation-induced) AA417921 0.89 ± 0.23 1.18 ± 0.21 3.61 ± 0.73 5.57 ± 0.89
cysteine and glycine-rich protein 1 AI935290 0.76 ± 0.12 0.62 ± 0.07 5.16 ± 0.5 1.51 ± 0.54
early development regulator 2 (polyhomeotic 2 homologue) AA598840 1.07 ± 0.41 1.01 ± 0.14 1.67 ± 0.1 3.85 ± 1.82
fatty acid binding protein 4, adipocyte AI652163 1.28 ± 0.63 0.62 ± 0 5.01 ± 0.9 2.84 ± 0.5
ﬁbroblast growth factor 7 (keratinocyte growth factor) AA009608 1.55 ± 0.81 2.33 ± 0.74 2.68 ± 1.99 7.14 ± 5.4
ﬁbroblast growth factor receptor 1 R54610 1.27 ± 0.05 0.91 ± 0.14 1.33 ± 0.52 2.86 ± 0.26
Homo sapiens COAS3 (COAS3) mRNA, complete cds AA018229 0.78 ± 0.06 1.72 ± 0.47 1.96 ± 0.05 1.74 ± 0.44
insulin-like growth factor binding protein 7 T53297  1 ± 0.26 0.64 ± 0.19 4.58 ± 1.63 2.7 ± 0.06
lectin, galactoside-binding, soluble, 1 (galectin 1) AI927284 0.83 ± 0.1 0.69 ± 0.08 3.51 ± 0.47 1.94 ± 0.11
matrix Gla protein AA155913 0.68 ± 0.1 0.94 ± 0.16 6.93 ± 0.8 2.46 ± 0.15
programmed cell death 5 AA416757 1.11 ± 0.22 1.32 ± 0.27 2.28 ± 0.61 2.02 ± 0.61
regenerating islet-derived 1 alpha AA625655 0.9 ± 0.14 0.78 ± 0.03 1.25 ± 0.2 2.77 ± 1.01
Sec61 gamma W96106 1.46 ± 0.53 1.75 ± 0.38 2.19 ± 0.1 3.88 ± 1.49
serine (or cysteine) proteinase inhibitor, clade H R71093 0.77 ± 0.27 0.86 ± 0.1 1.49 ± 0.71 5.7 ± 2.59
sorting nexin 14 AA524965 1.18 ± 0.42 0.95 ± 0.26  – ± – 4.64 ± 1.45
SPARC-like 1 (mast9, hevin) AA490471 1.18 ± 0.43 0.57 ± 0.16 2.05 ± 0.32 4.61 ± 4.27
TGFB-induced factor (TALE family homeobox) H51705 1.98 ± 0.71 1.65 ± 0.49 1.43 ± 0.59 3.98 ± 0.25
thymosin, beta 10 AA486085 0.89 ± 0.27 1.63 ± 0.2 2.46 ± 0.32 2.52 ± 0.46
transcription elongation factor B (SIII), polypeptide 1
(15 kDa, elongin C)
W81684 1.85 ± 0.96 0.87 ± 0.03 1.95 ± 0.58 3.24 ± 0.43
Signalling Molecules/Transcription Factors
AE binding protein 1 AA490462 1.77 ± 0.24 1.19 ± 0.19 3.16 ± 0.42 2.61 ± 0.21
basic transcription element binding protein 1 T63779 1.26 ± 0.19 1.02 ± 0.06 2.65 ± 1.03 2.29 ± 0.35
EphA5 (ephrin A5) H11658 1.77 ± 0.35 1.31 ± 0.44 3.34 ± 0.54 1.86 ± 0.51
eukaryotic translation initiation factor 4 A, isoform 1 AA650175 1.86 ± 0.27 1.47 ± 0.61 2.09 ± 0.35 2.74 ± 0.18
regulator of G-protein signalling 1 AA017417 0.83 ± 0.25 0.9 ± 0.11 7.61 ± 6.69 2.66 ± 0.98
regulator of G-protein signalling 16 AA453774  – ± – 2.19 ± 1.44 8.16 ± 3.47 5.11 ± 3.73
regulator of G-protein signalling 2, 24 kDa AI675670 1.53 ± 0.29 1.11 ± 0.08 2.51 ± 0.43 2.15 ± 0.64
Metabolic enzymes
aldolase A, fructose-bisphosphate AA775241 1.82 ± 0.27 1.69 ± 0.11 1.62 ± 0.64 2.62 ± 0.67
phosphoglycerate mutase 1 (brain) AW071046 0.92 ± 0.22 1.03 ± 0.13 1.48 ± 0.31 3.32 ± 1.28
steroid-5-alpha-reductase, alpha polypeptide 1 H16833 1.02 ± 0.33 1.84 ± 0.35 1.49 ± 0.64 17.56 ± 7.1
Motility/Adherence/Cytoskeletal proteins
actin, alpha 2, smooth muscle, aorta AA634006 1.04 ± 0.16 0.54 ± 0.06 5.78 ± 3.94 1.61 ± 0.08
actin, gamma 2, smooth muscle, enteric T60048 0.51 ± 0.12 0.56 ± 0.08 3.83 ± 0.49 1.36 ± 0.57
caldesmon 1 H51958 0.32 ± 0.13 0.73 ± 0.23 3.6 ± 0.76 1.48 ± 0.36
desmin AI972874 0.73 ± 0.33 0.57 ± 0.12 3.41 ± 1.38 1.01 ± 0.56
dynein, cytoplasmic, heavy polypeptide 1
ﬁbronectin 1
AA010589
AI262682
0.95 ± 0.34
0.87 ± 0.31
0.62 ± 0.2
0.64 ± 0.1
5.25 ± 1.41
2.44 ± 0.12
1.85 ± 0.64
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represented on the Incyte array, and 21/27 (78%) showed
a similar expression pattern in the conﬁrmatory experi-
ments. Many of the genes in this group were expressed
at higher levels in E. histolytica infection at 4 h, but not at
other time points (Fig. 4). Among the largest groupings
within the amoeba-speciﬁc genes were genes that encode
proteins involved in the junctions between cells (claudin
4, catenin, junction plakoglobin), and proteins implicated
in anchoring cells to the extracellular matrix (integrins
alpha 6, integrin beta 4, integrin beta 4 binding protein,
laminin gamma 2, laminin beta 3) (Table 3). Four distinct
serine protease genes showed increased expression only
in E. histolytica infected human colonic xenografts, while
both chains of the interferon g receptor were activated in
E. histolytica infection. Several genes showed increased
expression in E. histolytica and decreased expression in
S. ﬂexneri, including alpha defensin 3 (Fig. 4).
Conﬁrmation of differential gene expression by
Real-time PCR
In these experiments additional SCID-HU-INT mice were
infected with S. ﬂexneri or E. histolytica under the identical
conditions used for the microarray studies, and RNA was
obtained at 4 or 24 h after infection for analysis of gene
expression by Real-time PCR. We looked for changes in
expression levels for a total of 17 selected genes that had
demonstrated increased expression by microarray analy-
sis in E. histolytica infection alone (a-defensin, trypsin 2,
claudin 4, laminin g2, and serine 2 transmembrane pro-
tease), in S.  ﬂexneri  infection alone (vimentin, vinculin,
insulin-like growth factor binding protein 7, cysteine and
glycine-rich protein 1, eotaxin, and hypothetical protein
MGC3036), or in both S. ﬂexneri and E. histolytica infec-
tion (junB, metallothionein 1 L, GRO1 oncogene, interleu-
kin-6, and interleukin-11). As shown in Fig. 5, Real-time
PCR conﬁrmed the microarray ﬁndings of increased
expression of junB, metallothionein 1 L, GRO1, IL-6, and
IL-11 in both E. histolytica and S. ﬂexneri infection. The
pattern of expression for each of the genes was generally
similar for the microarray and Real-time PCR results, with
the exception of IL-11, which appeared to speciﬁcally be
increased late in shigella or E. histolytica  infection by
microarray analysis, but showed increased levels at both
4 and 24 h in the Real-time PCR analysis. Similarly, genes
identiﬁed as speciﬁcally increased in S. ﬂexneri infection
of human colonic xenografts by the microarray analysis
were conﬁrmed as shigella-speciﬁc by Real-time PCR, as
was their general pattern of expression (highest at S.
ﬂexneri infection at 4 h) (Fig. 5C). Real-time PCR analysis
also conﬁrmed that the genes identiﬁed as speciﬁcally
increased in E. histolytica  infection by the microarray
gelsolin (amyloidosis, Finnish type) H72027 1.79 ± 0.58 0.72 ± 0.08 4.77 ± 1.2 1.01 ± 0.31
lumican AA447781 0.94 ± 0.25 0.31 ± 0.12 2.73 ± 0.52 0.42 ± 0.22
moesin R22977 1.58 ± 1.2 1.22 ± 0.11 10.12 ± 6.58 5.66 ± 1.28
myosin, heavy polypeptide 11, smooth muscle AA126989 0.43 ± 0.25 0.46 ± 0.07 2.47 ± 0.31 0.26 ± 0.11
myosin, light polypeptide 9, regulatory AA877166 0.63 ± 0.28 0.59 ± 0.23 2.39 ± 0.49 0.99 ± 0.02
myosin, light polypeptide kinase AA487215 1.18 ± 0.52 0.75 ± 0.08 1.89 ± 0.22 0.93 ± 0.1
SH3-domain protein 5 (ponsin) AA459944 1.6 ± 0.17 1.21 ± 0.27 4.34 ± 0.46 0.96 ± 0.38
smoothelin AA449234 1.05 ± 0.3 0.62 ± 0.12 3.75 ± 0.26 1.35 ± 0.64
transgelin AA010664 1.06 ± 0.4 0.55 ± 0.18 4.95 ± 1.82 2.15 ± 1.05
tropomyosin 1 (alpha) AA047403 1.22 ± 0.28 0.42 ± 0.29 3.88 ± 0.52 1.86 ± 0.94
tubulin, alpha 1 (testis speciﬁc) AA180742 5.67 ± 4.7  1 ± 0.07 1.81 ± 0.33 2.04 ± 0.67
vimentin AA147847 0.92 ± 0.2 0.78 ± 0.1 3.19 ± 0.46 1.73 ± 0.57
vinculin AA486727 1.85 ± 1.1 0.87 ± 0.11 7.64 ± 5.23 5.44 ± 2.64
actin related protein 2/3 complex, subunit 1B (41 kDa) 1.23 ± 0.25 1.40 ± 0.07 2.87 ± 0.58 2.78 ± 0.85
Unknown
AA035657 AA035657 0.84 ± 0.18 0.23 ± 0.09 2.27 ± 0.12 0.3 ± 0.1
AA402898 AA402898 0.21 ± 0.04 0.73 ± 0.29 3.32 ± 0.05 2.86 ± 1.46
AA573736 AA573736 1.3 ± 0.48 1.05 ± 0.24 3.6 ± 0.31 2.58 ± 0.69
Homo sapiens cDNA FLJ20767 ﬁs, clone COL06986 AA043349 0.85 ± 0.26 0.76 ± 0.14 6.89 ± 1.48 0.92 ± 0.47
Homo sapiens mRNA; cDNA DKFZp586J021 (from clone
DKFZp586J021)
AW005791 1.51 ± 0.28 0.57 ± 0.05 3.32 ± 0.56 0.93 ± 0.23
hypothetical protein MGC3036 AA468776 0.6 ± 0.26 0.46 ± 0.04 7.74 ± 2.52 3.96 ± 2.2
KIAA0171 gene product AI935584 1.01 ± 0.09 0.54 ± 0.13 2.2 ± 0.3 1.01 ± 0.22
MSTP032 protein W60845 0.68 ± 0.14 0.35 ± 0.02 4.04 ± 0.75 1.88 ± 0.85
T64570 T64570 0.84 ± 0.09 0.98 ± 0.24 3.37 ± 1.31 2.01 ± 0.11
zinc ﬁnger protein 134 (clone pHZ-15) AA976255 0.67 ± 0.21 0.5 ± 0.1 3.72 ± 0.62 1.26 ± 0.38
The gene name, accession number, and mean fold increase (over the values from uninfected human colonic xenografts) from the replicates ±
the standard error of the mean are shown for each gene in E. histolytica infection at 4 h (A4), 24 h (A24), and S. ﬂexneri infection at 4 h (S4)
and 24 h (S24). When intensity values did not meet criteria to allow a mean to be obtained for a given gene at a given time-point, – ± – is shown.
Genes were placed within categories based on known functions or the functions of homologues.
Gene name Accession A4 A24 S4 S24
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Table 3. Genes showing increased expression in E. histolytica infection but not S. ﬂexneri infection at one or both time-points.
Gene Name Accession A4 A24 S4 S24
Stress response
cytochrome P450, subfamily IIS, polypeptide 1 AA971278 5.32 ± 2.96 0.92 ± 0.12 0.92 ± 0.57 1.58 ± 0.84
glucagon AI955772 0.72 ± 0.03 3.1 ± 0.2 0.16 ± 0.03 0.54 ± 0.13
cDNA FLJ31317 ﬁs, moderately similar to CYTOCHROME
P450 3A5
AA702706 2.33 ± 0.16 1.06 ± 0.21 0.85 ± 0.31 0.27 ± 0.1
Immune response/Inﬂammatory mediators/Cytokines/Chemokines
interferon gamma receptor 1 H11482 6.4 ± 3.96 1.09 ± 0.39 0.47 ± 0.33 0.81 ± 0.42
defensin, alpha 3, neutrophil-speciﬁc T81340 2.96 ± 0.24 0.93 ± 0.19 0.33 ± 0.12 0.22 ± 0.11
interferon gamma receptor 2 (interferon gamma transducer 1) AA969475 2.86 ± 0.69  1 ± 0.18 1.47 ± 0.46 1.49 ± 1.05
coagulation factor II (thrombin) receptor-like 1 (PAR2) AA454652 2.92 ± 0.06 1.10 ± 0.2 0.48 ± 0.22 0.35 ± 0.09
Growth factors/Tissue remodelling/Cell cycle regulators/Apoptosis-related
transmembrane 4 superfamily member 3 (tetraspanin family) AA045698 4.98 ± 2.83 1.31 ± 0.15 0.97 ± 0.26 1.04 ± 0.15
collagen, type XVI, alpha 1 AA088202 2.28 ± 0.22 0.83 ± 0.24 1.25 ± 0.46 0.48 ± 0.17
cytokeratin 20 AA522447 3.7 ± 0.08 1.35 ± 0.6 1.56 ± 0.33 1.49 ± 0.74
serine protease inhibitor, Kazal type 4 AA534438 0.74 ± 0.29 2.29 ± 0.16 1.53 ± 0.61 0.47 ± 0.07
collagen, type VII, alpha 1 AA598507 8.2 ± 6.26 2.84 ± 0.23 1.51 ± 0.55 0.84 ± 0.3
catenin (cadherin-associated protein), beta 1 (88 kDa) AA442092 2.67 ± 0.28 1.15 ± 0.28 1.01 ± 0.36 1.47 ± 0.48
SH3-domain GRB2-like endophilin B1 AA465147 1.66 ± 0.21 2.32 ± 0.24 1.35 ± 0.54 1.29 ± 0.11
fatty acid binding protein 6, ileal (gastrotropin) AI311734 0.58 ± 0.23 4.43 ± 0.46 1.07 ± 0.04 0.28 ± 0.12
tissue inhibitor of metalloproteinase 3 AA478662 1.15 ± 0.36 33.48 ± 29.09 1.68 ± 0.05 2.12 ± 1.25
discoidin domain receptor family, member 1 H41900 3.59 ± 0.89 0.84 ± 0.25 1.28 ± 0.48 0.41 ± 0.12
Signalling molecules/Transcription factors
E74-like factor 3 (ets domain transcription factor,
epithelial-speciﬁc)
AI984236 3.76 ± 0.31 0.92 ± 0.07 0.74 ± 0.09 0.34 ± 0.15
phospholipase A2, group IIA (platelets, synovial ﬂuid) T61271 2.38 ± 0.04 1.46 ± 0.09 0.27 ± 0.03 0.44 ± 0.08
H.sapiens mRNA for rho GDP-dissociation Inhibitor 1 BC028333 2.22 ± 0.12 1.25 ± 0.4 0.84 ± 0.17 0.9 ± 0.34
Metabolic Enzymes/Mucins
spermidine/spermine N1-acetyltransferase AA010811 2.01 ± 0.21 0.81 ± 0.15 0.4 ± 0.13 0.81 ± 0.25
alkaline phosphatase, intestinal AA190871 2.29 ± 0.26 0.84 ± 0.02 0.34 ± 0.02 0.23 ± 0.04
mucin 3B AI623883 3.6 ± 0.5 1.23 ± 0.18 1.04 ± 0.27 0.36 ± 0.12
glucosaminyl (N-acetyl) transferase 3, mucin type AI955582 5.85 ± 2.75 6.52 ± 2.8 0.83 ± 0.33 1.9 ± 1.03
Motilty/Adherence/Junctional proteins
integrin, beta 4 AA076430 2.13 ± 0.42 2.23 ± 0.19 0.75 ± 0.62 0.33 ± 0.09
laminin, gamma 2 (nicein (100 kDa), kalinin (105 kDa), BM600
(100 kDa)
AA677534 3.97 ± 0.16 4.17 ± 1.63 1.53 ± 0.42 1.24 ± 0.34
laminin, beta 3 (nicein (125 kDa), kalinin (140 kDa), BM600
(125 kDa))
AW007267 4.15 ± 0.44 1.19 ± 0.07 1.29 ± 0.44 1.08 ± 0.42
claudin 4 AA863314 3.53 ± 0.33 1.19 ± 0.13 1.12 ± 0.33 0.78 ± 0.08
junction plakoglobin R06417 2.42 ± 0.25 1.36 ± 0.33  1 ± 0.24 0.79 ± 0.08
integrin, alpha 6 R17993 2.49 ± 0.37 1.45 ± 0.44 1.63 ± 0.62 3.04 ± 1.38
integrin beta 4 binding protein AI017019 2.41 ± 0.75 0.77 ± 0.09 0.69 ± 0.17 1.13 ± 0.5
Transporters/Proteases
chloride intracellular channel 2 AI311800 0.2 ± 0.07 6.7 ± 3.05 0.61 ± 0.02  – ± –
transmembrane protease, serine 2 AA579186 7.56 ± 0.28 1.47 ± 0.39 1.17 ± 0.44 0.57 ± 0.15
protease, serine, 2 (trypsin 2) AA394198 3.01 ± 0.1 0.98 ± 0.13 0.62 ± 0.17 0.3 ± 0.08
protease, serine, 4 (trypsin 4, brain) AI308916 2.31 ± 0.12 1.15 ± 0.28 0.71 ± 0.09 0.46 ± 0.09
protease, serine, 8 (prostasin) R25981 2.31 ± 0.1 0.89 ± 0.15 2.44 ± 1.78 1.35 ± 1.3
Unknown
clone MGC:22924 IMAGE:4843302, mRNA, complete cds AA570148 2.65 ± 0.47 0.82 ± 0.17 0.21 ± 0.1 0.12 ± 0.03
cyclin L ania-6a AA465166 2.95 ± 0.88 1.14 ± 0.27 1.5 ± 0.19 1.86 ± 0.45
Homo sapiens cDNA FLJ31206 ﬁs, clone KIDNE2003335 T49815 4.38 ± 1.56 1.31 ± 0.11 0.5 ± 0.13 0.44 ± 0.02
The gene name, accession number, and mean fold increase (over the values from uninfected human colonic xenografts) from the replicates ± the
standard error of the mean are shown for each gene in E. histolytica infection at 4 h (A4), 24 h (A24), and S. ﬂexneri infection at 4 h (S4) and
24 h (S24). When intensity values did not meet criteria to allow a mean to be obtained for a given gene at a given time-point, - ± - is shown.
Genes were placed within categories based on known functions or the functions of homologues.
Fig. 3. Genes speciﬁcally expressed in S. ﬂexneri-infected human colonic xenografts at 4 and/or 24 h of infection. Gene expression proﬁles from 
three experiments looking at E. histolytica infection at 4 h (A4), and three experiments each for E. histolytica infection at 24 h (A24) and S. ﬂexneri 
infection at 4 h (S4) and 24 h (S24) are shown. Genes are listed by gene name, and those genes showing a similar expression pattern in the 
conﬁrmatory experiments using the Unigene array are marked by a (C). Those genes that were represented on the Unigene array but did not 
exhibit the same expression pattern are marked as (NC). The data are expressed as the log2 of the expression ratio, and the key for intensity of 
expression is:   Grey bars signify missing values secondary to failure of a given gene spot to meet minimal intensity 
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analysis were increased in E. histolytica-infected human
colonic xenografts, and not S.  ﬂexneri-infected human
colonic xenografts (Fig. 5). The only difference detected
was in the expression of a-defensin, which was increased
only at the 4 h time-point in the microarray analysis of
E. histolytica-infected human colonic xenografts (Fig. 5A),
but was elevated at both 4 and 24 h in the Real-time PCR
analysis (Fig. 5A and B).
Discussion
The clinical and pathologic endpoints of severe E. histolyt-
ica or S. ﬂexneri infection are clear – colitis, often with
mucosal ulceration, resulting in dysentery. We used a
transcriptional analysis to ask whether these endpoints
reﬂect a stereotypic gut response to any invasive patho-
gen, or whether the intestinal response to E. histolytica
and  S.  ﬂexneri  is pathogen-speciﬁc. Both E. histolytica
and S. ﬂexneri are human-speciﬁc pathogens, so we
used SCID-HU-INT mice and infected human colonic
xenografts to model each disease. Whereas a number of
recent microarray analyses have focused on the interac-
tions of pathogens with speciﬁc cell types in vitro, we were
interested in the tissue response to infection in vivo, and
used RNA isolated from sections of infected human colon.
This gives a complex readout from all the constituent cells
of the colon (e.g. epithelial cells, ﬁbroblasts, smooth mus-
cle cells, endothelial cells), as well as any inﬂuxing inﬂam-
matory cells, but offers the signiﬁcant advantage of
allowing us to see the results of cell–cell interactions,
where the effects of cytokines or mediators produced by
one cell type on the gene expression of another cell type
Fig. 4. Genes speciﬁcally expressed in E. histolytica-infected human colonic xenografts at 4 or 24 h of expression. Gene expression proﬁles from 
three experiments looking at E. histolytica infection at 4 h (A4), and three experiments each for E. histolytica infection at 24 h (A24) and S. ﬂexneri 
infection at 4 h (S4) and 24 h (S24) are shown. Genes are listed by gene name, and those genes showing a similar expression pattern in the 
conﬁrmatory experiments using the Unigene array are marked by a (C). Those genes that were represented on the Unigene array but did not 
exhibit the same expression pattern are marked as (NC). The data are expressed as the log2 of the expression ratio, and the key for intensity of 
expression is:   Grey bars signify missing values secondary to failure of a given gene spot to meet minimal intensity 
requirements for that experiment.Human colonic transcriptional response to dysentery 547
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will be detected. The chimeric nature of the SCID-HU-INT
mouse introduces another layer of complexity into the
analysis, as most of the colonic tissue, epithelial cells,
ﬁbroblasts, smooth muscle layers, are of human origin,
whereas most of the inﬂammatory cells, and some of the
endothelial cells will be of murine origin. We used human
gene arrays for these experiments, as our primary focus
was on the responses derived from colonic tissue, and we
elected not to alter the stringency of our hybridization
conditions to try and better detect altered expression of
murine genes. However, we cannot exclude the possibility
that some proportion of the human genes we detected
that displayed differential expression are actually the
homologous murine gene, expressed by mouse macroph-
ages, monocytes, neutrophils or endothelial cells, resident
in infected human colonic xenografts. Because our goal
was to analyse the global intestinal response to infection,
we do not consider the possible inclusion of such genes
to be a disadvantage, but we recognize that it may intro-
duce some bias into our results, as differentially
expressed murine genes that have more sequence iden-
tity to the homologous human gene would be more likely
to be detected in our analysis.
We found that there were pathogen-speciﬁc responses
to  E. histolytica  and  S.  ﬂexneri  in human colonic
xenografts, and these were most marked at the early time-
Fig. 5. Conﬁrmation of differential gene expression by Real-time PCR analysis. The graphs show the correlation of the mean fold increase in 
message levels in S. ﬂexneri or E. histolytica-infected human colonic xenografts compared to uninfected control human xenografts for a given 
gene by microarray analysis (x-axis) or by Real-time PCR (y-axis). Microarray values are the mean from the three experiments for each time-
point, and Real-time PCR message values are the mean from three separate human intestinal xenografts for each time point. Genes selected 
for conﬁrmatory Real-time PCR analysis that appeared to be increased in both E. histolytica and S. ﬂexneri infection based on microarray results 
(indicated by red symbols) were metallothionein 1 L (MTN1), GRO1 oncogene (GRO1), interleukin-6 (IL-6), JunB (JunB), and interleukin-11 (IL-
11). Genes selected for conﬁrmatory Real-time PCR analysis that appeared to increased in S. ﬂexneri infection alone (indicated by green symbols) 
were cysteine and glycine rich protein 1 (CGRP1), vinculin (vinculin), hypothetical protein MGC3036 (HP-MGC3036), insulin growth factor binding 
protein-7 (IGFP-7), vimentin (vimentin), and eotaxin (eotaxin). Genes selected for conﬁrmatory Real-time PCR analysis that appeared to increased 
in E. histolytica infection alone (indicated by blue symbols) were alpha-3-defensin (defensin), trypsin 2 (trypsin2), claudin 4 (claudin4), laminin 
g–2 chain (laminin), and transmembrane type 2 serine protease (TMSP). Results are shown for each gene in E. histolytica infection at 4 h (A), 
24 h (B), and S. ﬂexneri infection at 4 h (C) and 24 h (D). The boundary of twofold differential increase in expression in indicated for each graph.548 Z. Zhang and S. L. Stanley, Jr
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point, 4  h. By 24  h the transcriptional responses were
much more similar, and were dominated by the increased
expression of genes encoding molecules involved in
inﬂammation and tissue repair. For each infection, some
of the unique elements of the host response detected in
the transcriptional analysis could be related to the known
pathogenic mechanisms of S. ﬂexneri or E. histolytica. For
Shigella infection, the transcriptional analysis appeared to
reﬂect the ability of intracellular S. ﬂexneri to co-opt the
cytoskeletal machinery of infected epithelial cells. Shigella
entry into epithelial cells, and its subsequent cell to cell
spread, has been studied extensively in vitro, and is
dependent upon a number of host molecules, including
actin, actin-related protein 2/3 complex (ARP 2/3) vinculin,
myosin, and moesin (ezrin). (Tran et al., 2000) Strikingly,
the expression of the genes encoding these proteins was
speciﬁcally increased in S. ﬂexneri-infected human colonic
xenografts, consistent with bacterial utilization of these
host pathways in vivo. The increased expression of other
genes known to encode proteins that interact with actin,
including annexin A1, gelsolin and thymosin B10 raise the
possibility that these proteins could also play a role in
Shigella infection in vivo. (Yu et al., 1993; Choe et al.,
2002; Gerke and Moss, 2002) Shigella alteration of micro-
tubule function has been reported, and we found alter-
ations in dynein and tubulin gene expression in S. ﬂexneri-
infected human colonic xenografts. (Yoshida and
Sasakawa, 2003) Vimentin, an abundant intermediate ﬁl-
ament protein, is expressed and secreted by macrophages
in response to bacterial infection, and we found increased
expression of the vimentin gene in S.  ﬂexneri-infected
human intestinal xenografts. (Mor-Vaknin et al., 2003)
We found an increase in the expression of the smooth
muscle-speciﬁc genes encoding smoothelin, desmin, cys-
teine and glycine rich protein, and caldesmon 1, as well
marked increases in genes encoding collagen (Col1A1,
Col1A2, Col4A1, Col4A2, Col5A2 and Col6A3) in
S. ﬂexneri-infected human colonic xenografts. Because
S. ﬂexneri infection was generally conﬁned to the mucosal
region, without obvious involvement of the colonic muscle
layers, the source of these gene products may be acti-
vated ﬁbroblasts or the intestinal subepithelial myoﬁbro-
blasts located in the lamina propria under epithelial cells.
(Powell et al., 1999) The latter cells are known to play a
role in the repair of epithelial damage and colonic ulcer-
ations, and are activated by multiple mediators including
COX-2, interferong, TNFa, IL-1b, insulin dependent growth
factor 1 (IGF1), and TGFb. Colonic biopsies from individ-
uals with ulcerative colitis or Crohn’s colitis also show
increased expression of collagen genes, including
Col1A1, Col1A2, Col4A2 and Col6A3, indicating that
increased expression of these genes is a component of
the tissue response to inﬂammation within the colonic
mucosa. (Lawrance et al., 2001) Many of the genes acti-
vated in S. ﬂexneri infection, including Col1A2, Col4A2,
Col6A3, and the TGFb-induced factor, are speciﬁcally
induced in ﬁbroblasts by TGFb. (Verrecchia et al., 2001)
The apparent lack of activation of some of these ‘repair’
genes in E. histolytica-infected human colonic xenografts
may reﬂect a decreased activation of the TGFb and the
IGF pathways in amoebic infection, or simply reduced
inﬂammation and mucosal damage in E. histolytica com-
pared to S. ﬂexneri infection.
The increased expression of a number of genes that
could modulate the human colonic response to infection
was detected in S.  ﬂexneri-infected human colonic
xenografts. The regulators of G-protein signalling (RGS)
negatively regulate G-protein coupled receptor signalling,
but also can activate MAP kinase pathways in the
absence of G-protein coupled receptor signalling via G
pathways. Increased gene expression of two of the RGS
proteins (RGS-1 and RGS-16) has been reported in tis-
sues from animals septic from infection with Gram-
negative bacteria (Panetta et al., 1999). We found
increased expression of RGS1, RGS-16, and RGS-2 spe-
ciﬁcally in S. ﬂexneri-infected human intestinal xenografts,
suggesting a mechanism by which S. ﬂexneri could inﬂu-
ence the host responses by down regulating G-protein
signalling or activating MAP kinase signalling pathways.
Shigella ﬂexneri  infected human xenografts showed
increased expression of genes that are implicated in con-
trol of the cell cycle and programmed cell death. These
included the transcription factor BTEP-1, the pro-apoptotic
protein programmed cell death 5, and the antiproliferative
BTG family member 2. Apoptosis can be seen in lamina
propria cells obtained from rectal biopsies from individuals
with acute shigellosis, and has been linked to bacterial
LPS signalling via Toll receptor 2. (Aliprantis et al., 1999;
Raqib et al., 2002) Whether the pro-apoptotic molecules
identiﬁed in this transcriptional analysis, including pro-
grammed cell death 5 and galectin-1, play a role in this
process remains to be determined.
There were fewer genes that showed increased expres-
sion speciﬁcally in E. histolytica-infected human colonic
xenografts. This may reﬂect a less complex mode of patho-
genesis for amoeba, related in part to their purely extra-
cellular location. Entamoeba histolytica  trophozoites
added to a monolayer of mammalian cells exert a cyto-
pathic effect, with detachment of cells from the monolayer.
This effect, which may be key in allowing E. histolytica
trophozoites to invade through the mucosal layer, is medi-
ated by cysteine proteinases released from E. histolytica
that digest extracellular matrix proteins (Keene et al., 1990;
Zhang et al., 2000). Our data suggests that the cytopathic
effect may be a requisite and unique element of amoebic
pathogenesis in vivo.  Adhesion of epithelial cells to the
basement membrane requires integrin a6–b4 and laminin-
5, which form tight molecular complexes linking the plasmaHuman colonic transcriptional response to dysentery 549
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membrane of epithelial cells to the basement membrane
(Falk-Marzillier  et al., 1998). We found signiﬁcantly
increased expression of the genes encoding two of the
components of laminin-5 (laminin b3 and laminin a2) and
both integrin a6 and integrin b4 chains in E. histolytica
infected human colonic xenografts, which, in the simplest
interpretation, could be consistent with an attempt to main-
tain epithelial cell adhesion to the extracellular matrix by
replacing proteins cleaved by E. histolytica cysteine pro-
teinases. We also found increased expression of the genes
encoding b-catenin, claudin 4, and junction plakoglobin;
proteins that are comprise intercellular epithelial cell junc-
tions. These results differ from those seen in inﬂammatory
bowel disease, where a downregulation of the expression
of junctional molecules with disease has been observed
(Gassler et al., 2001). It is known that E. histolytica tro-
phozoites can disrupt tight junctions between epithelial
cells, suggesting that the increase in expression of some
of the junctional proteins represents a compensatory
response to speciﬁc effects of E. histolytica on epithelial
cells. (Li et al., 1994; Leroy et al., 2000).
One mechanism for diarrhoea is altered ion transport
by  colonic epithelial cells. The trypsin serine proteases
have been linked to increased Cl(–) secretion by colonic
epithelial cells via their activation of the proteinase acti-
vated receptor 2 (PAR2) in human colon (Mall et al.,
2002). We found increased expression of the genes
encoding two trypsin serine proteases and PAR2 in
E. histolytica  infected human colonic xenografts. The
serine proteases, prostasin (serine protease 8), and trans-
membrane serine protease 2 (TMPRSS2) were recently
shown to directly regulate epithelial sodium channel
(ENaC) expression (with prostasin activating Na
+ chan-
nels, whereas TMPRSS2 decreased sodium currents and
ENaC protein levels). Expression of the genes for each of
these proteases was increased in E. histolytica-infected
human colonic xenografts (Donaldson et al., 2002). We
also found increased expression of the gated chloride
channel ClC-2, a molecule implicated in chloride secretion
by  intestinal epithelial cells (Mohammad-Panah et al.,
2001). Whether any of these changes correspond to a
physiologic role for these proteins and altered ion trans-
port in E. histolytica  induced diarrhoea remains to be
determined.
Although we were able to detect genes that are specif-
ically expressed in S. ﬂexneri or E. histolytica infection,
our results strongly suggest that most of the intestinal
response is stereotypic, with the same patterns of gene
expression seen in each infection. Not unexpectedly,
given the histopathologic ﬁndings of inﬂammation and
mucosal damage seen in both E. histolytica infection and
S.  ﬂexneri  infection, the stereotypic element of the
response was dominated by genes encoding proteins
mediating inﬂammation, stress responses, and tissue
repair. Most of the major signalling and regulatory path-
ways that control or induce cytokine production were rep-
resented among the genes showing increased expression
in infectious colitis caused by S. ﬂexneri or E. histolytica.
Induction of JNK and p38 MAP kinases was evident by
the increased expression of genes in the AP-1 family
(c-jun, c-fos, JunB, JunD), and p38 MKK3, respectively,
whereas activation of the NF-kB pathway was demon-
strated by the increased expression of the IkBa  gene.
Multiple genes known to be induced by TNFa or IL-1 (IL-
1b, IL-6, IL-8, MCP-1, MCP-3, MIP-3
_, Gro1–3, IkBa,
ENA-78, and COX-2) were differentially expressed in S.
ﬂexneri and E. histolytic-induced colitis, consistent with an
important role for these cytokines in the pathogenesis of
dysentery and gut inﬂammation. (Seydel et al., 1997;
Zhang  et al., 2001;2003; Ciesielski et al., 2002; Kwon
et al., 2002; Chen et al., 2003; Tsuzaki et al., 2003) Many
of these genes also show increased expression in colonic
biopsies from individuals with ulcerative colitis or Crohn’s
colitis (e.g. IL-1b, IL-8, IL-6, Gro1–3, lipocalin, MCP-1,
interferon-inducible proteins, SOD-2, serum amyloid pro-
teins) (Lawrance et al., 2001), again consistent with the
concept that different initial injuries may induce gut inﬂam-
mation through a limited number of pathways.
Genes linked to the adaptive response to hypoxia
showed increased expression in both E. histolytica and
S. ﬂexneri  infected human colonic xenografts, including
the transcription factor HIF-1, and its target genes, lactate
dehydrogenase A, enolase 1 and 2, fructose-
bisphosphate aldolase, glyceraldehyde-3-phosphate
dehydrogenase, HIF-1 responsive RTP801, and Glut-1
(solute carrier family 2, member 1). HIF-1 gene expres-
sion can be increased by TNFa under normoxic condi-
tions, so it remains unknown at this point whether the
activation of these genes reﬂects an important role for
hypoxia/ischaemic injury in the pathogenesis of amoebic
and bacterial dysentery (Mathan and Mathan, 1991), with
direct triggering of HIF-1 through hypoxia, or whether acti-
vation of these genes is a component of the inﬂammatory
response mediated by TNFa. (Scharte et al., 2003) Other
genes known to be activated by stress/injury and also by
cytokines, including the genes encoding superoxide dis-
mutase, serum amyloid proteins, and the metallothioneins
(MTs), were also increased in both E. histolytica and S.
ﬂexneri infected colonic xenografts. Metallothionein gene
expression, which is regulated by multiple factors includ-
ing metal-responsive transcription factors (MTF-1), IL-6
and TNFa (probably via AP-1), and g-INF response ele-
ments, is known to be increased in sepsis, but has not
previously been linked to infectious colitis (Sciavolino and
Vilcek, 1995; Chinnaiyan et al., 2001). Interestingly, the
expression of MT1H and MT1G was decreased in colonic
biopsies from individuals with Crohn’s colitis or ulcerative
colitis compared to healthy controls (Lawrance et al.,550 Z. Zhang and S. L. Stanley, Jr
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2001) suggesting MT gene expression may be a distin-
guishing marker for infectious colitis.
The colonic inﬂammation and the resultant tissue dam-
age seen in E. histolytica and S. ﬂexneri induced colitis
arises in the face of multiple counter-regulatory measures.
The gene encoding the SOCS-3 protein, which inhibits the
actions of multiple cytokines, and is increased in the
colonic mucosa of individuals with inﬂammatory bowel
disease, as well as in immune-mediated and chemical-
induced animal models of colitis, showed increased
expression in both S. ﬂexneri and E. histolytica infection
(Greenhalgh and Hilton, 2002). Increased expression of
the gene encoding the cytokine interleukin-11, which is
known to inhibit IL-1, IL-6, and TNFa release from mac-
rophages, and has recently shown efﬁcacy in treating
individuals with Crohn’s disease, was seen at the late
time-points in both E. histolytica and S. ﬂexneri-infected
human colonic xenografts (Sands et al., 2002). Activation
of the MMP1, MMP12, and MMP17 genes was accompa-
nied by increased expression of their inhibitors TIMP-1
and TFPI-2 (Herman et al., 2001). Even in the early
phases of disease, before marked mucosal damage was
present in some cases, genes encoding proteins involved
in the induction and regulation of angiogenesis and ﬁbro-
sis (e.g. cryptic gene, cysteine rich angiogenic inducer,
connective tissue growth factor, angiopoeitin, stanniocal-
cin 1, and BMP antagonist) were already activated in both
S.  ﬂexneri and E. histolytica-infected colonic xenografts
(Bell  et al., 2001). We know that the gut inﬂammation
associated with either E. histolytica or S. ﬂexneri infection
eventually resolves, after antimicrobial therapy or host
immune/inﬂammatory responses eliminate the causative
organism. The endogenous inhibitors of cytokines and
proteases, produced even in the initial phases of the
inﬂammatory response, as well as the early induction and
regulation of tissue repair and remodeling factors, may be
critical in mediating this resolution.
In summary, our data show that from the host perspec-
tive, infectious colitis caused by either S.  ﬂexneri or E.
histolytica  results in the activation of highly conserved
inﬂammatory, stress response, and tissue repair/regener-
ation pathways. By 24  h of infection, these responses
dominate the transcriptional response in both S. ﬂexneri
and  E. histolytica-infected human colonic xenografts.
Many of these pathways are activated in inﬂammatory
bowel disease and in intestinal ischaemia, so our molec-
ular dissection of the colonic response to injury may shed
light on a variety of intestinal diseases and provide new
targets for controlling gut inﬂammation. On the back-
ground of these conserved responses, we were also able
to detect transcriptional patterns that were speciﬁc for
Shigella or E. histolytica. These speciﬁc pathways were
most marked early in infection, consistent with the concept
that the forms of injury may be unique, but once the
epithelial cells are damaged, the gut responses become
stereotypic. Some components of the unique patterns of
gene expression in S.  ﬂexneri  or  E. histolytica  colonic
infection were consistent with pathogenic mechanisms
that had been identiﬁed in in vitro studies, but had not
previously been shown to occur in vivo. Other transcrip-
tional ﬁndings represent previously unrecognized molec-
ular responses to E. histolytica or S. ﬂexneri infection, and
may provide new insights into the pathophysiology of each
disease. The results of this study led us to look at the
effects of inhibiting TNFa in amoebic colitis (Zhang et al.,
2003), and we anticipate that the products of other genes
identiﬁed by this analysis will be tested for their role in the
pathogenesis of S. ﬂexneri or E. histolytica infection.
Experimental procedures
Bacteria and amoeba
Shigella ﬂexneri WT2457T (provided by Dr F. Noriega, Center for
Vaccine Development, University of Maryland School of Medi-
cine) was grown on tryptic soy broth with aeration for 24 h before
inoculation into SCID-HU-INT mice. Entamoeba histolytica strain
HM1:IMSS was grown on BI-S-33 as previously described (Stan-
ley et al., 1990).
SCID-HU-INT mice
Human colonic xenografts were placed into the subscapular
region of 6–8 week old SCID mice as previously described (Sey-
del  et al., 1997). Incisions were closed with Michel clips, and
grafts were allowed to develop for 10 weeks before use.
Infection of human intestinal xenografts
Human colonic xenografts in SCID-HU-INT mice (groups of 4)
were infected by direct intraluminal inoculation with either 1 ¥ 10
6
E. histolytica trophozoites or 1 ¥ 10
7 S. ﬂexneri. A group of three
donor-matched human colonic xenografts were sham infected by
inoculation with media alone. At 4 or 24  h following infection,
animals were sacriﬁced, and the grafts were removed for RNA
isolation. The RNA samples from the four infected human
xenografts were pooled, and the RNA samples obtained from the
sham-infected human intestinal xenografts were pooled. A total
of three separate experiments comparing four amoebic-infected
and three donor-matched uninfected intestinal xenografts were
performed for amoebic infection at 4 h, and three separate exper-
iments comparing four amoebic infected and three donor
matched uninfected human intestinal xenografts were performed
for amoebic infection at 24 h. An identical protocol was used for
S. ﬂexneri infection, with three separate experiments comparing
four shigella-infected human intestinal xenografts and three
donor-matched uninfected human intestinal xenografts per-
formed for shigella infection at the 4 and 24 h time-points. An
additional conﬁrmatory set of microarray experiments for each
infection and each time point using four donor-matched human
colonic xenografts for each group and arrays produced by Incyte
was also performed.Human colonic transcriptional response to dysentery 551
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RNA isolation
A 500 mg section of each human colonic xenograft was obtained
and saved in 4 ml RNALater reagent (Ambion, Austin, TX). RNA
was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA)
and puriﬁed with RNeasy mini kit (Qiagen, Valencia, CA) follow-
ing exactly to the manufacture’s protocol. For the conﬁrmatory
Incyte array screening, poly A + mRNA was obtained from total
RNA using the Oligotex spin column (Qiagen, Valencia, CA)
exactly according to the manufacturer’s instructions.
Probe synthesis
For the Stanford array analysis, probe synthesis was performed
using  the  Genisphere  3DNA™  submicro  labelling  protocol
as described by the manufacturer, using 5 mg of total RNA, and
3 ml of Cy3 or Cy5 RT primer (detailed protocol at: http://
www.genisphere.com/pdf/submicro1x_8-15-02.pdf). For the con-
ﬁrmatory Incyte arrays, mRNA was ﬁrst quantiﬁed using
Ribogreen dye (Molecular Probes, Eugene, OR), then 25–100 ng
of mRNA were separated on an Agilent 2100 Bioanalyzer to
examine size distribution (Agilent Technologies, Palo Alto, CA).
Subsequent steps of probe synthesis, hybridizations, scanning,
and data acquisition were performed using the protocols
described by Yue et al. (2001). Two hundred ng of puriﬁed RNA
were converted to Cy3-(infected xenografts) or Cy-5 (uninfected
xenografts) probe using a custom labelling kit (Incyte Genomics).
Labelled Cy3 and Cy5 cDNA products were combined and
puriﬁed on a size exclusion column, concentrated by ethanol
precipitation, than resuspended in a hybridization buffer (Yue
et al., 2001).
Array hybridization
Hybridization of labelled cDNA probes on the Stanford human
array which contains approximately 43 000 spots was performed
using the Genisphere protocol (vide supra). Spots on the Stan-
ford array consist of 85.8% I.M.A.G.E. consortium clones
(sequence veriﬁed human cDNA clones), 9.8% clones from the
Cancer Genome Anatomy Project (CGAP), and 3.6% control
spots (details at http://www.microarray.org/sfgf/jsp/home.jsp).
Hybridization of the human Unigene 1 array (Incyte Genomics)
which contains 9248 PCR products derived from unique clones
from the human Unigene collection and proprietary clones from
Incyte was performed using the protocol of Yue et al.  (2001).
After hybridization, microarrays were scanned with an Axon
GenePix 4000 A ﬂuorescent scanner (Axon Instruments, Foster
City, CA) and Gene Pix image acquisition software (Axon) at
535 nm for Cy3 and 625 nm for Cy5. For Stanford arrays, the
Scanalyze program (http://rana.lbl.gov/EisenSoftware.htm) was
used to quantify signal and background intensity for each spot,
and the ratio of normalized intensities was obtained as the dif-
ferential expression ratio for the speciﬁc gene in the two RNA
samples. Genes had to exhibit a greater than twofold difference
than background intensity in at least one experimental condition
to be considered for further analysis. The data was analysed
using Microsoft Access™ software, and genes exhibiting a differ-
ential expression ratio ≥ 2 in two of the three experiments for S.
ﬂexneri infection at 4 or 24 h, and for E. histolytica infection at 4
or 24 h were considered positive. Data from the Access analysis
was imported into the Cluster program (http://rana.lbl.gov/
EisenSoftware.htm), log transformed, and ratios grouped using
average linkage hierarchial clustering. Data are presented using
Treeview software (http://rana.lbl.gov/EisenSoftware.htm) –
genes are listed by gene name and each gene is only listed once,
even if it had duplicates on the array, regardless of whether the
accession numbers were identical. For Incyte arrays, the Gem-
Tools software (Incyte Genomics) was used to quantify signal and
background intensity for each spot, and the ratio of the two
corrected signal intensities was calculated and expressed as the
differential expression ratio for the speciﬁc gene in the two mRNA
samples (Yue et al., 2001). Global normalization was done by
calculating a balance coefﬁcient to correct variations in data,
possibly the result of unequal amounts of sample, poor quality
sample, or ﬂuorescent dye fade. The average signal from all
elements in the Cy3 channel was divided by the average signal
from all elements in the Cy5 channel. The Cy5 signal for each
element was then multiplied by the balance coefﬁcient, before
calculating the expression ratio (Cy3/Cy5). This gives rise to the
balanced differential expression ratio. Data from Incyte indicates
that for the same element under the same conditions, differential
expression ratio values all fall between ±1.4 (Yue et al., 2001).
For these experiments, we analysed the data using the cut-off
recommended by Incyte (≥1.7) for differential expression.
Table 4. Primers utilized in Real-time PCR conﬁrmatory assays.
Gene name Forward primer Reverse primer
Cysteine-glycine rich protein CTCAGGGCAAAGGGAAAGGT GGCCAGGGCTCTGTTCTTG
a-Defensin CTCAGCAGCAGAATCCCAGAGT AAAACATGGCCTGCTATTGCA
Hypothetical protein TTCCAACCCCAAAAATATTCCA CTTCGTCTTCTGAACGTGCCTAT
IGFBP-7 GTGCCATGCATCCAATTCC CGGCACCTTCACCTTTTTTC
18S rRNA AGTCCCTGCCCTTTGTACACA GCCTCACTAAACCATCCAATCG
Trypsin2 ATCACCCTGGCAGGAATCCT TGAGCCAGGCTGAGTGTGAA
Vinculin GAGAAGCATGTTTGAAGACCAAGAA AGATCACCAAAAAGAACCCAAAACT
Vimentin AACAGCTTTCAAGTGCCTTTCTG AAATCTTGTAGGAGTGTCGGTTGTTA
JunB AAGTCCTTACCTCTTCCGGAGATG GCCTGGCTCAACATGCTACTAA
Metallothionein- 1 l CTGCAAAGGGACGTCAGACA GCAAACGGGTCAGGGTTGTA
GRO1-a ACATGCCAGCCACTGTGATAGA CATTCCCCTGCCTTCACAAT
TMPRSS2 GGCGAAGAAGAGAAAGATGTGTTT ACCCTTCCCCTGGTTGGA
Laminin-g2 GGGATTCTGGCTGATGTGAAG TCAAGAGCCTGGGTATTGTAGCA
Claudin4 AGTCCTCTGCCCCTTCCAA CACAAAGAAGGAAGAGGAAAAACC
IL-6 CATGGGCACCTCAGATTGTTG TGCCCAGTGGACAGGTTTC
Eotaxin TGTCACGTGTGGGCAATGTT CATCTTTGCCAGGACCTTTACAA
IL-11 GGGCTGCACCTGACACTTG TGTTTCGCCCCCAGTACTG552 Z. Zhang and S. L. Stanley, Jr
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Real-time PCR
Reverse transcription was performed using 2  mg total RNA,
oligo(dT) as primers, and AMV reverse transcriptase (Fisher
Research, Pittsburg, PA). Primers for PCR were designed using
Primer Express Software (Applied Biosystems, Foster City, CA)
and are shown in Table 4. Real-time PCR was carried out in a
total volume of 10 ml using 200 nm of primer pairs, 5 ml of 2¥
SYBR Green PCR Mastermix (Applied Biosystems), varying con-
centrations of cDNA template, with conditions of the recom-
mended universal thermal cycling parameters using a ABI 7700
(Applied Biosystems). Each reaction was run in triplicate. Rela-
tive quantiﬁcation of gene expression was performed using the
comparative CT method. The human 18S ribosomal RNA was
used as an internal control and the uninfected xenograft as sam-
ple control.
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